This Act may be cited as the “Medication Access and Training Expansion Improvement Act” or the “MATE Improvement Act”.

(a) In general.—Section 303 of the Controlled Substances Act (21 U.S.C. 823) is amended—

(1) by redesignating the second subsection designated as subsection (l) as subsection (m); and

(2) in subsection (m)(1), as so redesignated—

(A) in subparagraph (A)—

(i) in clause (iv)—

(I) in subclause (I)—

(aa) by inserting “the American Academy of Family Physicians, the American Podiatric Medical Association, the Academy of General Dentistry, the American Optometric Association,” before “or any other organization”;

(bb) by striking “or the Commission” and inserting “, the Commission”; and

(cc) by inserting “, or the Council on Podiatric Medical Education” before the semicolon at the end; and

(II) in subclause (III), by inserting “or the American Academy of Family Physicians” after “Association”; and

(ii) in clause (v), in the matter preceding subclause (I)—

(I) by striking “osteopathic medicine, dental surgery” and inserting “osteopathic medicine, podiatric medicine, dental surgery”; and

(II) by striking “or dental medicine curriculum” and inserting “or dental or podiatric medicine curriculum”; and

(B) in subparagraph (B)—

(i) in clause (i)—

(I) by inserting “the American Pharmacists Association, the Accreditation Council on Pharmacy Education, the American Psychiatric Nurses Association, the American Academy of Nursing, the American Academy of Family Physicians,” before “or any other organization”; and

(II) by inserting “, the American Academy of Family Physicians,” before “or the Accreditation Council”; and

(ii) in clause (ii)—

(I) by striking “or accredited school” and inserting “, an accredited school”; and

(II) by inserting “, or an accredited school of pharmacy” before “in the United States”.

(b) Effective Date.—The amendments made by subsection (a) shall take effect as if enacted on December 29, 2022.